View Clinical Trial (Medical Research Study)


"Twenty-Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fixed Dose Regimens of Thalidomide and Placebo on CSF and Plasma Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Signup
Browse Studies

City:   Sun City
State:   Arizona
Zip Code:   85351
Conditions:   Alzheimer's Disease
Purpose:   This is a 24-week, randomized, double-blind, placebo-controlled study of the effect of thalidomide and placebo on CSF (cerebral spinal fluid) and plasma biomarkers in patients with mild to moderate Alzheimer's disease. This study will evaluate the effects of 24 weeks of treatment with Thalidomide on plasma biomarkers.
Study Summary:   A lumbar puncture will be done before treatment (baseline), and at 24 weeks to collect CSF for the quantification of biomarkers. As an exploratory effort, we will test the effects of thalidomide on the same biomarkers in the plasma and will determine if detectable changes mirror changes observed in the CSF.
Criteria:   Inclusion Criteria: - Subjects must have a screening diagnosis of Probable Alzheimer's disease according to National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA) criteria. - Subjects must have a Mini-Mental State Examination (MMSE) score of 12-26 - Subject must live at home. - Must have a caregiver to participate in this study
NCT ID:   NCT01094340
Primary Contact:   Study Director
Carolyn Liebsack, BSN
Banner Sun Health Research Institute

Backup Contact:   N/A
Location Contact:   Sun City, Arizona 85351
United States

Marwan Sabbagh, MD
Phone: 623-832-6500
Email: marwan.sabbagh@bannerhealth.com

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   April 25, 2015
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click I Am Interested In This Study

Full Name:
 
Email Address:
Confirm Email:
Daytime Phone (eg. 555-555-5555):
City:
State:
Zip Code:
Best Time to Call:
Questions/Comments:
  • NEARBY STUDIES

    (updated 30 minutes ago)
Within 25 Miles

Bunion Surgery (Bunionectomy) - Phoenix AZ

Gout - Phoenix AZ

Gout - Phoenix AZ

Uterine Fibroids - Phoenix AZ

Type II Diabetes - Phoenix AZ

Gout and Heart Disease - Phoenix AZ

Alzheimer’s Disease - Sun City AZ

Elderly Dementia Risk - Phoenix AZ

Elderly Dementia Risk - Sun City AZ

Chronic Obstructive Pulmonary Disorder (COPD) - Phoenix AZ

Asthma - Scottsdale AZ

Back Pain - Phoenix AZ

Irritable Bowel Syndrome - Phoenix AZ

Asthma - Phoenix AZ

Chronic Obstructive Pulmonary Disease (COPD) - Phoenix AZ

Constipation Due To Prescription Pain Medication - Phoenix AZ

Atopic Dermatitis (Eczema) - Phoenix AZ

Psoriasis - Phoenix AZ

Type II Diabetes - Phoenix AZ

Fibromyalgia - Tempe AZ

Cold Sores - Phoenix AZ

Osteoarthritis of the Knee - Phoenix AZ

Chronic Constipation - Phoenix AZ

Chronic Low Back Pain - Phoenix AZ

Diabetic Peripheral Neuropathy - Phoenix AZ

Fibromyalgia - Phoenix AZ

Fibromyalgia - Phoenix AZ

Rheumatoid Arthritis - Phoenix AZ

Chronic Obstructive Pulmonary Disease - Peoria AZ

Alzheimer’s Disease - Phoenix AZ

Diabetic Neuropathy - Phoenix AZ

Genital Herpes/Cold Sore (HSV1/HSV2) - Phoenix AZ

Adult Autism - Phoenix AZ

Morton's Neuroma - Phoenix AZ

Parkinson's Disease - Phoenix AZ

Osteoarthritis of the Knee - Phoenix AZ

Chronic Low Back Pain - Phoenix AZ

Chronic Constipation - Glendale AZ

High Cholesterol - Glendale AZ

Within 50 Miles

Gout - Chandler AZ

Gout - Gilbert AZ

Gout - Mesa AZ

Multiple Sclerosis - Gilbert AZ

Healthy Volunteers (Overweight) - Scottsdale AZ

Smoking Cessation - Scottsdale AZ

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Tempe AZ

Within 100 Miles